These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29067759)

  • 1. Who benefits from fixed-dose combinations? Two-year statin adherence trajectories in initiators of combined amlodipine/atorvastatin therapy.
    Schaffer AL; Buckley NA; Pearson SA
    Pharmacoepidemiol Drug Saf; 2017 Dec; 26(12):1465-1473. PubMed ID: 29067759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does a single-pill antihypertensive/lipid-lowering regimen improve adherence in US managed care enrolees? A non-randomized, observational, retrospective study.
    Hussein MA; Chapman RH; Benner JS; Tang SS; Solomon HA; Joyce A; Foody JM
    Am J Cardiovasc Drugs; 2010; 10(3):193-202. PubMed ID: 20387911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Benefit of Fixed-Dose Combination of Amlodipine and Potent Atorvastatin in Patients With Concomitant Hypertension and Hypercholesterolemia.
    Lin CP; Hsu TJ; Tung YC; Hsiao FC; Chou SH; Lin YS; Chen SW; Chu PH
    J Am Heart Assoc; 2024 May; 13(9):e033780. PubMed ID: 38686894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [One year persistence of atorvastatin and amlodipine fixed dose combination versus atorvastatin therapy].
    Simonyi G; Ferenci T
    Orv Hetil; 2016 Mar; 157(11):425-9. PubMed ID: 26947091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does a fixed-dose combination of amlodipine and atorvastatin improve persistence with therapy in the Australian population?
    Bartlett LE; Pratt N; Roughead EE
    Curr Med Res Opin; 2018 Feb; 34(2):305-311. PubMed ID: 28945105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amlodipine + atorvastatin single pill is the most effective choice for primary prevention.
    Aalbers J
    Cardiovasc J Afr; 2010; 21(4):243. PubMed ID: 20838732
    [No Abstract]   [Full Text] [Related]  

  • 7. Adherence with single-pill amlodipine/atorvastatin vs a two-pill regimen.
    Patel BV; Leslie RS; Thiebaud P; Nichol MB; Tang SS; Solomon H; Honda D; Foody JM
    Vasc Health Risk Manag; 2008; 4(3):673-81. PubMed ID: 18827917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence with a single pill versus two pills of amlodipine and atorvastatin: the Australian experience, 2006-2010.
    Simons LA; Ortiz M; Calcino G
    Med J Aust; 2011 Aug; 195(3):134-7. PubMed ID: 21806531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea.
    Liew D; Park HJ; Ko SK
    Clin Ther; 2009 Oct; 31(10):2189-203; discussion 2150-1. PubMed ID: 19922890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Time an Important Problem in Management of Hypertension and Hypercholesterolemia by Using an Amlodipine-Atorvastatin Single Pill Combination?
    Zeng R; Wang M; Zhang L
    Med Sci Monit; 2016 Jul; 22():2648-55. PubMed ID: 27459306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of amlodipine-atorvastatin combination on fibrinolysis in hypertensive hypercholesterolemic patients with insulin resistance.
    Fogari R; Derosa G; Lazzari P; Zoppi A; Fogari E; Rinaldi A; Mugellini A
    Am J Hypertens; 2004 Sep; 17(9):823-7. PubMed ID: 15363826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of fix dose combination (atorvastatin and amlodipine) in treatment of uncontrolled hypertension and dyslipidemia.
    Bashir S; Sherwani MU; Shabbir I; Batool A
    J Ayub Med Coll Abbottabad; 2011; 23(3):97-100. PubMed ID: 23272446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits of a fixed-dose combination of bisoprolol and amlodipine in the treatment of hypertension in daily practice: results of more than 4000 patients.
    Czarnecka D; Koch EM; Gottwald-Hostalek U
    Curr Med Res Opin; 2015 May; 31(5):875-81. PubMed ID: 25753136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amlodipine/atorvastatin fixed-dose combination: a review of its use in the prevention of cardiovascular disease and in the treatment of hypertension and dyslipidemia.
    McKeage K; Siddiqui MA
    Am J Cardiovasc Drugs; 2008; 8(1):51-67. PubMed ID: 18303938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient Adherence to Olmesartan/Amlodipine Combinations: Fixed Versus Extemporaneous Combinations.
    Levi M; Pasqua A; Cricelli I; Cricelli C; Piccinni C; Parretti D; Lapi F
    J Manag Care Spec Pharm; 2016 Mar; 22(3):255-62. PubMed ID: 27003555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International open-label studies to assess the efficacy and safety of single-pill amlodipine/atorvastatin in attaining blood pressure and lipid targets recommended by country-specific guidelines: the JEWEL programme.
    Richard Hobbs FD; Gensini G; John Mancini GB; Manolis AJ; Bauer B; Genest J; Feldman RD; Harvey P; Jenssen TG; da Silva PM;
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):472-80. PubMed ID: 19407658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved attainment of blood pressure and cholesterol goals using single-pill amlodipine/atorvastatin in African Americans: the CAPABLE trial.
    Flack JM; Victor R; Watson K; Ferdinand KC; Saunders E; Tarasenko L; Jamieson MJ; Shi H; Bruschi P
    Mayo Clin Proc; 2008 Jan; 83(1):35-45. PubMed ID: 18174006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amlodipine/Atorvastatin: a review of its use in the treatment of hypertension and dyslipidaemia and the prevention of cardiovascular disease.
    Curran MP
    Drugs; 2010; 70(2):191-213. PubMed ID: 20108992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Switching from Treatment with Amlodipine and Atorvastatin Using Two Pills to an Equal Dose of Single-Pill Therapy in Japanese Outpatients.
    Kawada Y; Kubo T; Baba Y; Hirota T; Tanioka K; Yamasaki N; Kitaoka H
    Acta Med Okayama; 2020 Apr; 74(2):103-108. PubMed ID: 32341583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prior experience with cardiovascular medicines predicted longer persistence in people initiated to combinations of antihypertensive and lipid-lowering therapies: findings from two Australian cohorts.
    Bartlett LE; Pratt NL; Roughead EE
    Patient Prefer Adherence; 2018; 12():835-843. PubMed ID: 29805251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.